TriSalus Life Sciences, Inc. Warrant (TLSIW) Stock Price

TLSIWStock
$0.88
Market Cap
P/E
PEG Ratio
Div yield
Beta1.79

TLSIW Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-7.25%
Price vs S&P 500 (4W)8.67%
VGM Score27.87

Industry Peers — Surgical & Medical Instruments(140)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
TLSIWTriSalus Life Sciences, Inc. Warrant
D$0.88
SYKStryker CorporationCBC$330.69
MMM3M CompanyCDC$174.34
BSXBoston Scientific Corp.CBD$46.84
BDXBecton, Dickinson and Co.BDB$189.52
MDLNMedline Inc. Class A common stockCDC$35.28
RMDResMed Inc.CBB$240.33
DXCMDexCom, Inc.DBB$90.82
WSTWest Pharmaceutical Services, Inc.DCB$337.47
SOLVSolventum CorporationCCB$91.12
BAXBaxter International Inc.BDB$26.13

About TriSalus Life Sciences, Inc. Warrant

TriSalus Life Sciences develops drug delivery systems and immune-oncology therapeutics targeting difficult-to-treat liver and pancreatic cancers. The company markets PEDD (Pressure Enabled Drug Delivery) infusion systems, including its latest TriNav device with SmartValve technology, which are in clinical use today. It is also advancing nelitolimod (SD-101), an investigational agent designed to enhance immune response against hepatocellular carcinoma, pancreatic cancer, and other liver tumors.